tecvayli
janssen-cilag international n.v. - teclistamab - myeloma multiplex - daganatellenes szerek - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
talvey
janssen-cilag international n.v. - talquetamab - myeloma multiplex - daganatellenes szerek - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
atacand plus 16 mg/12,5 mg tabletta
astrazeneca kft. - candesartan; hydrochlorothiazide -
alkohol pharmamagist 80% oldatos injekció
pharmamagist kft. - etanol -
crestor 10 mg filmtabletta
astrazeneca kft. - rosuvastatin -
crestor 20 mg filmtabletta
astrazeneca kft. - rosuvastatin -
crestor 40 mg filmtabletta
astrazeneca kft. - rosuvastatin -
lindynette 75 mikrogramm/20 mikrogramm bevont tabletta
richter gedeon nyrt. - ethinylestradiol; gestodene -
lindynette 75 mikrogramm/30 mikrogramm bevont tabletta
richter gedeon nyrt. - ethinylestradiol; gestodene -
milligest bevont tabletta
richter gedeon nyrt. - gestodene; ethinylestradiol -